Luba Greenwood, J.D.

Ms. Greenwood is the CEO of Kojin Therapeutics and a leading figure in the biotech and digital health world. She has vast experience as an executive, investor, and company builder in the biotech, life sciences, diagnostics, and tech sectors. Most recently, she has served as the Managing Partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital, which she has built and launched. Previously, Ms. Greenwood served in leadership roles at Google Life Sciences, Verily, and was a VP of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub. Ms. Greenwood  has led $5B+ in deals and investments across multiple therapeutic areas and life sciences globally. Additionally, she has co-founded companies in the oncology, AI/ML, women’s health and microbiome spaces. She is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology.